Accordingly, we showed that expression of the epithelial marker, E-cadherin in CIS-treated hypoxic A549 cells was further reduced upon HCQ treatment, suggesting appearance of cells with mesenchymal phenotype. The gene discussed is CDH1; the disease is in situ carcinoma.